Skip to main content

Abintus Bio, INC

San Diego, CA
United States

Abintus Bio

Abintus Bio is developing cutting-edge in vivo CAR therapies that allow for powerful CAR T cells to be generated directly in a patient’s body, eliminating the need for time-consuming and costly collection, engineering and re-infusion of patient T cells. The innovative Abintus approach aims to reprogram T cells inside the body to attack and eliminate tumors.

Program Name(s)
Therapy Acceleration Program